Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA